Finance

Lists
MIRA:NASDAQ
Mira Pharmaceuticals Inc
US$0.66
+1.77%
(+0.012) 1D
US$0.65
-1.49% (-0.0098)
After hours
Closed: ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRA...
Open
US$0.64
High
US$0.66
Low
US$0.61
Mkt. cap
27.65 ሚ
Avg. vol.
133.67 ሺ
Volume
92.46 ሺ
52-wk high
US$1.69
52-wk low
US$0.51
EPS
-US$1.38
Beta
1.64
Shares outstanding
42.02 ሚ
No. of employees
3
Open
US$0.64
High
US$0.66
Low
US$0.61
Mkt. cap
27.65 ሚ
Avg. vol.
133.67 ሺ
Volume
92.46 ሺ
52-wk high
US$1.69
52-wk low
US$0.51
EPS
-US$1.38
Beta
1.64
Shares outstanding
42.02 ሚ
No. of employees
3
News stories
From web sources and news partners
Reuters
Reuters
·
ከ17 ሰዓቶች በፊት
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
marketscreener.com
marketscreener.com
·
ከ6 ሰዓቶች በፊት
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
qz.com
qz.com
·
ከ6 ሰዓቶች በፊት
How much of the S&P 500 is Nvidia? Concentration explained
Traders Union
Traders Union
·
ከ6 ሰዓቶች በፊት
S&P 500 gains $1.2 trillion in a week, Peter Tuchman notes
About Mira Pharmaceuticals Inc
CEO-
Employees3
Founded2020
Headquartersማያሚ, ፍሎሪዳ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websitemirapharmaceuticals.com
Analyst ratings
Based on 1 analyst giving stock ratings to MIRA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MIRA in the last 3 months
Highest
Current US$0.66
US$3.50 (+430.46%)
Average
US$3.50 (+430.46%)
Lowest
US$3.50 (+430.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$3.50
+430.5%
10/22/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$8.00
+1,112.5%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
412.64 ሺ
496.54 ሺ
524.78 ሺ
705.79 ሺ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
904.35 ሺ
5.33 ሚ
578.70 ሺ
450.33 ሺ
Operating expense
1.32 ሚ
5.82 ሚ
1.10 ሚ
1.16 ሚ
Total operating expenses
1.32 ሚ
5.82 ሚ
1.10 ሚ
1.16 ሚ
Operating income
-1.32 ሚ
-5.82 ሚ
-1.10 ሚ
-1.16 ሚ
Other non operating income
-12.44 ሺ
-396.00
-
-
EBT including unusual items
-1.14 ሚ
-5.98 ሚ
-1.15 ሚ
-1.21 ሚ
EBT excluding unusual items
-1.31 ሚ
-5.77 ሚ
-1.15 ሚ
-1.21 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.14 ሚ
-5.98 ሚ
-1.15 ሚ
-1.21 ሚ
Net profit margin
-
-
-
-
Earnings per share
-0.07
-
-
-
Interest and investment income
15.70 ሺ
53.17 ሺ
44.91 ሺ
35.13 ሺ
Interest expense
-
-
-
-
Net interest expenses
15.70 ሺ
53.17 ሺ
44.91 ሺ
35.13 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች